Genpharmasec Limited announced that the Board of Directors of the Company at their meeting held on November 1, 2022, accepted Resignation of Mr. Ulhas Deosthale as Chief Financial Officer of the Company with effect from 28 October 2022, however Mr. Ulhas Deosthale will continue as Whole Time Director (WTD) of the Company. Based on the recommendation of Nomination and Remuneration Committee appointed Mr. Sohan Chaturvedi as a Chief Financial Officer [Key Managerial Personnel] of the Company with effect from 01st November, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 INR | +1.98% |
|
+6.19% | -55.89% |
May. 24 | Genpharmasec Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
May. 24 | Genpharmasec Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-55.89% | 13.68M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- 531592 Stock
- News Genpharmasec Limited
- Genpharmasec Limited Announces CFO Changes